• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影响179例新生儿茶碱处置的因素

Factors influencing theophylline disposition in 179 newborns.

作者信息

Gilman J T, Gal P, Levine R S, Hersh C B, Erkan N V

出版信息

Ther Drug Monit. 1986;8(1):4-10. doi: 10.1097/00007691-198603000-00002.

DOI:10.1097/00007691-198603000-00002
PMID:3961896
Abstract

The pharmacokinetics of intravenous theophylline were prospectively studied in 179 premature babies. Interrelated variables were analyzed for their influence on theophylline serum clearance. Gestational age, gender, duration of treatment, body weight, and Apgar scores were not found to correlate significantly with theophylline clearance. Weak but statistically significant correlations were found between serum clearance and postnatal (p less than 0.005) and postconceptional age (p less than 0.01). No significant difference in mean serum clearance (Cls) values was found between small-for-gestational-age (SGA) patients (Cls = 17.9 +/- 5.3 ml/kg/h) and appropriate-for-gestational-age (AGA) patients (Cls = 18.8 +/- 5.8 ml/kg/h). Conversely, asphyxiated patients had significantly lower mean clearance values than nonasphyxiated patients (16.4 +/- 5.3 ml/kg/h vs. 20.2 +/- 5.4 ml/kg/h, respectively, p less than 0.001). Volume of distribution for theophylline (n = 147) was 0.77 +/- 0.17 L/kg; there was no significant difference in distribution volumes between asphyxiated and nonasphyxiated patients or between SGA and AGA patients. Step-wise multiple regression analysis revealed postnatal age as the most important determinant of theophylline clearance among the variables analyzed (p less than 0.01). Postconceptional age had a statistically significant association with theophylline clearance in the entire group (n = 179, p less than 0.05). Duration of treatment had a small and statistically borderline effect (p less than 0.10) on theophylline clearance among nonasphyxiated infants when age factors were considered. Analysis of covariance confirmed the statistical effects of both postnatal age and asphyxia on theophylline serum clearance.

摘要

对179名早产儿进行了静脉注射氨茶碱的药代动力学前瞻性研究。分析了相关变量对氨茶碱血清清除率的影响。未发现胎龄、性别、治疗持续时间、体重和阿氏评分与氨茶碱清除率有显著相关性。血清清除率与出生后(p<0.005)和孕龄(p<0.01)之间存在弱但具有统计学意义的相关性。小于胎龄(SGA)患者(Cls = 17.9±5.3 ml/kg/h)与适于胎龄(AGA)患者(Cls = 18.8±5.8 ml/kg/h)的平均血清清除率(Cls)值无显著差异。相反,窒息患者的平均清除率值显著低于未窒息患者(分别为16.4±5.3 ml/kg/h和20.2±5.4 ml/kg/h,p<0.001)。氨茶碱的分布容积(n = 147)为0.77±0.17 L/kg;窒息患者与未窒息患者之间或SGA患者与AGA患者之间的分布容积无显著差异。逐步多元回归分析显示,在分析的变量中,出生后年龄是氨茶碱清除率的最重要决定因素(p<0.01)。孕龄与整个组(n = 179,p<0.05)的氨茶碱清除率有统计学意义的关联。在考虑年龄因素时,治疗持续时间对未窒息婴儿的氨茶碱清除率有较小且在统计学上接近临界的影响(p<0.10)。协方差分析证实了出生后年龄和窒息对氨茶碱血清清除率的统计学影响。

相似文献

1
Factors influencing theophylline disposition in 179 newborns.影响179例新生儿茶碱处置的因素
Ther Drug Monit. 1986;8(1):4-10. doi: 10.1097/00007691-198603000-00002.
2
Effect of asphyxia on theophylline clearance in newborns.
South Med J. 1982 Jul;75(7):836-8. doi: 10.1097/00007611-198207000-00017.
3
Maturational changes of theophylline pharmacokinetics in preterm infants.早产儿茶碱药代动力学的成熟变化
Clin Pharmacol Ther. 1989 May;45(5):461-8. doi: 10.1038/clpt.1989.59.
4
Factors affecting theophylline pharmacokinetics in premature infants with apnea.影响呼吸暂停早产儿茶碱药代动力学的因素。
Dev Pharmacol Ther. 1980;1(1):6-15.
5
A randomized, double-blind, placebo-controlled trial of the effects of prophylactic theophylline on renal function in term neonates with perinatal asphyxia.一项关于预防性使用茶碱对足月围产期窒息新生儿肾功能影响的随机、双盲、安慰剂对照试验。
Pediatrics. 2000 Apr;105(4):E45. doi: 10.1542/peds.105.4.e45.
6
Transient cholestasis in newborn infants with perinatal asphyxia.围产期窒息新生儿的短暂性胆汁淤积
Can J Gastroenterol. 2003 Mar;17(3):179-82. doi: 10.1155/2003/108473.
7
Inadequacy of FDA dosing guidelines for theophylline use in neonates.美国食品药品监督管理局(FDA)关于新生儿使用茶碱的给药指南存在不足。
Drug Intell Clin Pharm. 1986 Jun;20(6):481-4. doi: 10.1177/106002808602000609.
8
[Multicenter clinical study on umbilical cord arterial blood gas parameters for diagnosis of neonatal asphyxia].脐动脉血气参数诊断新生儿窒息的多中心临床研究
Zhonghua Er Ke Za Zhi. 2010 Sep;48(9):668-73.
9
The influence of asphyxia on phenobarbital dosing requirements in neonates.
Dev Pharmacol Ther. 1984;7(3):145-52. doi: 10.1159/000457157.
10
Kinetics of theophylline in apnea of prematurity in small for gestational age babies.小于胎龄儿早产儿呼吸暂停时茶碱的动力学
Indian Pediatr. 1996 Mar;33(3):181-7.

引用本文的文献

1
Theophylline dosing and pharmacokinetics for renal protection in neonates with hypoxic-ischemic encephalopathy undergoing therapeutic hypothermia.茶碱在接受治疗性低温的缺氧缺血性脑病新生儿中的剂量和药代动力学用于肾保护。
Pediatr Res. 2020 Dec;88(6):871-877. doi: 10.1038/s41390-020-01140-8. Epub 2020 Sep 12.
2
Neonatal exposure to drugs in breast milk.新生儿通过母乳接触药物。
Pharm Res. 2004 Apr;21(4):555-66. doi: 10.1023/b:pham.0000022401.14710.c5.
3
Population pharmacokinetics of theophylline during paediatric extracorporeal membrane oxygenation.
小儿体外膜肺氧合期间茶碱的群体药代动力学
Br J Clin Pharmacol. 2003 Jan;55(1):23-31. doi: 10.1046/j.1365-2125.2003.01735.x.
4
Ontogeny of hepatic and renal systemic clearance pathways in infants: part II.婴儿肝脏和肾脏全身清除途径的个体发生:第二部分。
Clin Pharmacokinet. 2002;41(13):1077-94. doi: 10.2165/00003088-200241130-00005.
5
Dose conversion from aminophylline to theophylline in preterm infants.早产儿氨茶碱到茶碱的剂量转换
Arch Dis Child Fetal Neonatal Ed. 1994 Jul;71(1):F51-2. doi: 10.1136/fn.71.1.f51.
6
Influence of endogenous and exogenous effectors on the pharmacokinetics of theophylline. Focus on biotransformation.内源性和外源性效应物对茶碱药代动力学的影响。重点关注生物转化。
Clin Pharmacokinet. 1995 Apr;28(4):287-314. doi: 10.2165/00003088-199528040-00003.
7
The population pharmacokinetics of theophylline in neonates and young infants.新生儿和婴幼儿中茶碱的群体药代动力学。
J Pharmacokinet Biopharm. 1989 Feb;17(1):47-66. doi: 10.1007/BF01059087.
8
Clinical pharmacology of the perinatal period and early infancy.围产期和婴儿早期的临床药理学。
Clin Pharmacokinet. 1989;17 Suppl 1:13-28. doi: 10.2165/00003088-198900171-00004.
9
Therapeutic drug monitoring in the neonate and paediatric age group. Problems and clinical pharmacokinetic implications.新生儿及儿童年龄组的治疗药物监测。问题及临床药代动力学影响。
Clin Pharmacokinet. 1990 Jul;19(1):1-10. doi: 10.2165/00003088-199019010-00001.